NUCLEIC ACIDS FOR THE TREATMENT OF HMGB1-RELATED PATHOLOGIES
The present invention relates to the use of synthetic double-stranded nucleic acid or nucleic acid analogue molecules with a bent shape structure for the prevention and treatment of pathologies induced directly or indirectly by the HMGB1 protein.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
25.06.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to the use of synthetic double-stranded nucleic acid or nucleic acid analogue molecules with a bent shape structure for the prevention and treatment of pathologies induced directly or indirectly by the HMGB1 protein. |
---|---|
Bibliography: | Application Number: EP20050773148 |